Advertisement
Canada markets open in 8 hours
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7327
    +0.0003 (+0.05%)
     
  • CRUDE OIL

    83.92
    +0.35 (+0.42%)
     
  • Bitcoin CAD

    87,638.75
    +161.91 (+0.19%)
     
  • CMC Crypto 200

    1,385.37
    +2.79 (+0.20%)
     
  • GOLD FUTURES

    2,349.50
    +7.00 (+0.30%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ futures

    17,764.50
    +197.00 (+1.12%)
     
  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • NIKKEI 225

    38,057.50
    +429.02 (+1.14%)
     
  • CAD/EUR

    0.6828
    +0.0007 (+0.10%)
     

Aphria: Analysts’ Recommendations and Target Price

Aphria: Analysts’ Recommendations and Target Price

Aphria (APHA) (APHQF) had one of the worst months in December. Aphria stock fell nearly 24%. On December 18, the company announced that it will introduce its oral strip to the German market. The product will work in conjunction with a previously announced agreement with Rapid Dose for the exclusive right to manufacture, license, and distribute Rapid Dose’s QuickStrip oral strip. As a result, the stock rose nearly 7.8% during the day.